Allergies and Autoimmune Disease Study
We are no longer enrolling participants in this study.
By studying a person’s genetic profile and environmental factors, we hope to develop personalized therapies that can help in treating, managing and ultimately preventing inflammatory and immune disorders.
Allergies and Autoimmune Disease Study at ITMI: Why participate
Any patients of O&O Alpan and Inova with a diagnosis of asthma, inflammatory or autoimmune diseases – and their family members – can participate in this study.
If you are interested in participating, contact Kathi Huddleston. A member of our research team will discuss the study with you and answer your questions.
Allergies and Autoimmune Disease Study at ITMI: Who is eligible
This study would not be possible without people like you, even though this research may not directly help you or your family.
By joining this study, you will have a role in helping our researchers:
- Gather data we need to learn how several factors work together to predict how people respond to allergies and inflammatory and immune disorders
- Identify new ways to predict and treat inflammatory and immune responses – and hopefully prevent these diseases
Allergies and Autoimmune Disease Study at ITMI: What will happen if I enroll
If you participate in this study, we will collect samples and ask you to complete a survey.
- Samples: We will collect small samples of blood and saliva (and, optionally, urine). Typically, samples are collected at an O&O Alpan office or Inova Fairfax Medical Campus. If you are unable to come to one of those locations, we will collect these samples at your physician’s office or an alternative location.
- Survey: We will ask you to complete a brief questionnaire about your medical and family history, diet, social environment and healthcare behaviors. The clinical research staff may ask you the questions during your visit or contact you by telephone.
There is no cost to participate.
Join the Allergies and Autoimmune Disease Study at ITMI
To learn more about this study, contact Kathi Huddleston, PhD, Director, Clinical Research or call ITMI at 703-776-8199.